Anti-Seizure Drugs (ASDs) 1 Flashcards
What percentage of patients with epilepsy can have their seizures controlled with medication?
65-80%
Pharmacotherapy of epilepsy is highly individualized and requires titration of the dose to optimize
ASD therapy
Many of the new ASDs are only approved for
Adjunct Therapy
ASDs can cause a rash called
Steven Johnsons Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN)
Can cause Fetal Abnormalities and birth defects (“Major Congenital Malformations” or MCMs)
ASDs
What are the three mechanisms of action of ASDs?
- ) Modification of ionic conductance
- ) Enhancement of inhibitory transmission
- ) Inhibition of excitatory transmission
ASDs enhance inhibitory transmission (IPSPs) by increasing
GABAergic transmission
ASDs inhibit excitatory transmission (EPSPs) by decreasing
Glutamergic transmission
The ability of Na+ channels to recover from inactivated state is inhibited by ASDs. This prolongs the
Inactivation state of Na+ channels
Neurons undergo depolarization and fire action potentials at high frequencies during
Seizures
Selective inhibition of this pattern of firing should reduce
Seizures
Inhibition of the high-frequency firing is thought to be mediated by reducing the ability of Na+ channels to recover from
Inactivation
Prolonging the inactivation of the Na+ channels results in reducing the ability of neurons to
Fire at high frequencies
Recall that inactivated channels are inactive because they are blocked by the
Inactivation gate
Oldest nonsedative antiseizure drug (1938)
Phenytoin (Dilantin, Phenytek)
A prodrug of phenytoin designed for parenteral use
Fosphenytoin
What is the major mechanism of action of Phenytoin?
Na+ Channel Inhibiton
Indications: 1) Simple Partial 2) Complex Partial 3) Secondarily Generalized and 4) Primary Generalized tonic-clonic seizures
Phenytoin
What are the contraindications for Phenytoin?
May exacerbate myoclonic and absence seizures
Phenytoin is especially contraindicated in
Lennox-Gastaut Syndrome
The therapeutic dose for most patients is
10-20 ug/mL
Only free, unbound phenytoin molecules can penetrate the bloodbrain barrier and exert
Pharmacological effects
What percentage of Phenytoin is bound to plasma protein?
90%
Conditions such as hypoalbuminemia and uremia can significantly impact plasma levels of
Phenytoin
Phenytoin is eliminated hepatically by conversion to
Inactive Metabolites
At low blood levels, phenytoin metabolism follows
First-order kinetics
At therapeutic range and higher, non-linear relationship of dosage and plasma concentration occurs. This is
Zero order kinetics
Is extensively metabolized in the liver and this process becomes saturated at about the doses needed for therapeutic effect
Saturation Kinetics
Thus, phenytoin at low doses exhibits first-order kinetics, but saturation or zero-order kinetics develop as we reach the
Therapeutic plasma concentration
Phenytoin is 90% bound to plasma proteins (albumin). Increased proportions of free (active) drug are observed in newborn, in patients with
Hypoalbuminemia and in uremic patients
Other protein-binding drugs, including other ASDs (e.g. valproate) can compete for protein binding sites, resulting in increases in
Free Phenytoin
Drugs that induce or inhibit hepatic enzymes can impact phenytoin metabolism and thus impact
Plasma concentrations
Phenytoin itself induces
Hepatic Enzymes
Nystagmus, diplopia, ataxia, drowsiness are common dose-related CNS adverse effects requiring dosage adjustment
Phenytoin
Seen in 20-40% of patients chronically taking phenytoin
Gingival hyperplasia
Phenytoin can cause vitamin D deficiency which may result in
Osteomalacia
A category D (bad) teratogen
Phenytoin
What percentage of Carbamazepine is protein-bound?
75%
The active metabolite of Carbamazepine is?
10,11-epoxide
The t½ of Carbamazepine falls significantly over the first few weeks of therapy due to the induction of
-Metabolize itself (autoinduction)
Hepatic enzymes (CYPs)
CYP-inducing drugs such as phenytoin may increase the metabolism of
Carbamazepine
What are three common symptoms of Carbamazepine?
Hyponatremia, Leukopenia, Rash
Can induce Stevens-Johnson Syndrome
-Incidence is highest in Asian Populations
Carbamazepine
The HLA allele B*1502 (10-15% incidence in ethnic Han Chinese; 2-4% in ethnic South Asian) has been identified as a marker for
Carbamazepine-induced SJS and toxic epidermal necrolysis (TEN)
FDA approved in 2000 for partial seizures with or without secondary generalization
-Generally fewer adverse effects than CBZ (and phenytoin)
Oxcarbazepine (Trileptal)
Is more likely to cause hyponatremia than carbamazepine
-Important consideration for patients taking diuretics
Oxcarbazepine
What are the three mechanisms of action of Valproic Acid (or Valproate)
Na+ Channel Inhibition, Inhibition of T-type Ca2+ channels, and Increased GABA produciton
Valproic Acid (Valproate) is contraindicated for patients with
Liver Disease
When the fraction of bound drug reduces as the total concentration of drug is increased
Saturable binding
Highly protein-bound, but the binding is saturable
Valproate
Valproate is eliminated through hepatic metabolism, mainly by
UGT enzymes and beta-oxidation
At least 10 metabolites have been identified, with one at least one (4-ene VPA) being implicated for the hepatotoxicity associated with
Valproate
Crosses the placenta and concentrations in cord serum blood may be 5-X higher than the mother due to higher binding in the fetal compartment
Valproate
Enzyme-inducing ASDs (phenytoin, carbamazepine) can decrease the concentration of
Valproate
Which type of antibiotics reduce valproate serum concentrations?
Carbapenems
As a high proportion of valproate is bound to albumin, it can displace
Phenytoin and other drugs from albumin
Can inhibit hepatic enzymes, so it can inhibit the metabolism of other ASDs like phenytoin, phenobarbital, lamotrigine and lorazepam when co-administered
Valproate
What are the three major side effects of Valproate?
Weight gain, hepatotoxicity, and teratogenic effects
A rare complication with valproate that is frequently fatal
Fulminant hepatitis
Has teratogenic effects such as neural tube defects (up to 20-fold higher risk than the general population), particularly spina bifida
Valproate
Can give a rash in 10% of patients and rarely progresses to serious systemic illness (SJS)
Lamotrigine
Lamotrigine does not induce or inhibit
CYP enzymes
While lamotrigine has not been shown to affect the efficacy of oral contraceptives (OCs), it has been reported that OCs can reduce effective concentrations of
Lamotrigine
Co-administration with valproate can double the plasma concentration of
Lamotrigine
Co-administration with phenytoin or carbamazapine can reduce plasma concentrations of
Lamotrigine
Was the most frequently used ASD for many years, but its use has declined considerably since the appearance of newer-generation ASDs with improved tolerability
Phenytoin
Had the best balance of efficacy and tolerability in the large cooperative VA study that also included phenytoin phenobarbital, and primidone
-Became the standard treatment for focal seizures
Carbamazepine
Remains the most effective ASD for idiopathic generalized epilepsy with generalized tonic-clonic seizures, and should remain a drug of first choice for men with generalized epilepsy
Valproate
An important first-line ASD for focal seizures and generalized tonic-clonic seizures, although it is not FDA approved for initial monotherapy (only conversion-to-monotherapy)
Lamtrigotine
Less sedating and has fewer cognitive adverse effects than traditional ASDs
Lamtrigotine
ASDs that inhibit voltage gated Ca2+ channels do so by inhibiting the
T-type Ca2+ channels
T-type channel inhibitors reduce the pacemaker current that underlies the
Thalamic rythm in spikes and waves seen in generalized absence seizures
Specifically used for absence seizures
-Inhibits T-type Ca2+ currents
Ethosuximide (Zarontin)
Has the adverse effects of leukopenia, thrombocytopenia, pancytopenia, and aplastic anemia
Ethosuximide (Zarontin)
Activation of the GABAA receptor inhibits the postsynaptic cell by increasing the inflow of
-Will hyperpolarize the neuron
Cl- ions into the cell
Enhance GABAA receptor–mediated inhibition of action potential by enhancing inflow of Cl–
Benzodiazepines and barbiturates
Used for virtually every seizure type, especially when attacks are difficult to control
-The oldest of the currently available antiseizure drugs
Phenobarbital
Used to treat status epilepticus
Phenobarbital
Binds to GABAA receptor, prolonging the opening of the
Chloride channels
Also reproted to inhibit glutamate release, enhance GABA transmission, and inhibit Na+ and Ca2+ conductance
Phenobarbital
Is metabolized to phenobarbital in the body
Primidone
Phenobarbital is metabolized by
Hepatic Microsomal Enzymes (CYP)
Drugs metabolized by hepatic enzymes (e.g. oral contraceptives ) can be more rapidly degraded when co-administered with
Phenobarbital
What are 4 major side effects of phenobarbital?
Sedation, Cognitive impairment, Hyperactivity in children, and CNS depression
The ASD of choice for generalized absence seizures
Ethosuximide
Are typically used as adjunctive therapy and have limited data to support monotherapy use
Benzodiazapines
What are the two GABA analogs?
Tiagabine and Vigabatrine
Functions by Inhibition of GABA transporter (GAT-1)
Tiagabine (Gabitril)
Reduces reuptake of GABA by neurons and glial cells
Tiagabine (Gabitril)
Inhibits the breakdown of GABA by targeting the enzyme GABA transaminase (GABA-T)
Vigabatrin (Sabril)
Only available through a restricted distribution program due to concerns about retinal toxicity and permanent visual field loss
Vigabatrin (Sabril)
Selective inhibitors of voltage-gated Ca2+ channels containing the α2δ1 subunit
-Originally designed to be GABA analogs
Gabapentin and Pregabalin
What are the two main adverse effects of Gabapentin (neurontin) and Pregabalin (Lyrica)?
Weight gain and Somnolence
Effective as a monotherapy, but can exacerbate myoclonic and absence seizures
Gabapentin
Not effective for absence, myoclonic, or primary generalized tonic-clonic seizures
-Also used to treat Fibromyalgia
Pregabalin (Lyrica)